Corcept Therapeutics Incorporated shares owned by Ameriprise Financial
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Ameriprise Financial
from 13F filings
Historical chart of Ameriprise Financial investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by Ameriprise Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $28M | 339k | 83.11 |
| 2025-06-30 | $31M | 419k | 73.40 |
| 2025-03-31 | $30M | 265k | 114.22 |
| 2024-12-31 | $16M | 317k | 50.39 |
| 2024-09-30 | $18M | 392k | 46.28 |
| 2024-06-30 | $12M | 353k | 32.49 |
| 2024-03-31 | $7.4M | 293k | 25.19 |
| 2023-09-30 | $8.1M | 296k | 27.25 |
| 2023-06-30 | $7.2M | 322k | 22.25 |
| 2023-03-31 | $7.9M | 363k | 21.66 |
| 2022-12-31 | $7.6M | 374k | 20.31 |
| 2022-09-30 | $9.9M | 387k | 25.64 |
| 2022-06-30 | $9.4M | 397k | 23.78 |
| 2022-03-31 | $9.0M | 401k | 22.52 |
| 2021-12-31 | $8.0M | 403k | 19.80 |
| 2021-09-30 | $8.7M | 440k | 19.68 |
| 2021-06-30 | $10M | 460k | 22.00 |
| 2021-03-31 | $11M | 471k | 23.79 |
| 2020-12-31 | $12M | 446k | 26.16 |
| 2020-09-30 | $8.0M | 462k | 17.41 |
| 2020-06-30 | $8.1M | 483k | 16.82 |
| 2020-03-31 | $6.0M | 501k | 11.89 |
| 2019-12-31 | $6.4M | 528k | 12.10 |
| 2019-09-30 | $7.7M | 543k | 14.13 |
| 2019-06-30 | $6.7M | 601k | 11.15 |
| 2019-03-31 | $7.2M | 616k | 11.74 |
| 2018-12-31 | $8.4M | 629k | 13.36 |
| 2018-09-30 | $8.9M | 632k | 14.02 |
| 2018-06-30 | $8.9M | 564k | 15.72 |
| 2018-03-31 | $14M | 851k | 16.45 |
| 2017-12-31 | $15M | 852k | 18.06 |
| 2017-09-30 | $5.8M | 302k | 19.30 |
| 2016-12-31 | $845k | 116k | 7.26 |
| 2013-09-30 | $5.0k | 3.3k | 1.51 |
| 2012-06-30 | $943k | 210k | 4.49 |
| 2011-06-30 | $904k | 227k | 3.99 |
| 2011-03-31 | $949k | 223k | 4.25 |
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated